Literature DB >> 7568545

Maximum variance of late component event related potentials (190-240 ms) in unmedicated schizophrenic patients.

J Anderson1, E Gordon, R J Barry, C Rennie, P J Beumont, R Meares.   

Abstract

The averaging of individual late component event related potential (ERP) responses, particularly P300, has revealed significant differences between schizophrenic patients and normal subjects. However, the averaging process removes the variability of the individual epochs that constitute that average. The response-variance-curve (RVC) method quantifies the variability of the individual epochs and allows examinations of windows of maximum variance. In this study, we examine the complementary nature of the RVC method to the traditional averaging approach. The averaged N200 and P300 ERP components differed significantly between the schizophrenic and normal groups, but not between the unmedicated and medicated schizophrenic patients. The RVC measure, on the other hand, revealed systematic differences in variability, maximal between 190 and 240 ms, between the unmedicated and medicated schizophrenic patients. The RVC measure therefore provides a focused time frame in which to examine dysfunctions in information processing and macroscopic scale changes in brain function due to medication.

Entities:  

Mesh:

Year:  1995        PMID: 7568545     DOI: 10.1016/0165-1781(95)02556-c

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  2 in total

1.  Increased temporal variability of auditory event-related potentials in schizophrenia and Schizotypal Personality Disorder.

Authors:  Yong-Wook Shin; Giri Krishnan; William P Hetrick; Colleen A Brenner; Anantha Shekhar; Frederick W Malloy; Brian F O'Donnell
Journal:  Schizophr Res       Date:  2010-12       Impact factor: 4.939

2.  Brain Network Analysis of EEG Recordings Can Be Used to Assess Cognitive Function in Teenagers With 15q13.3 Microdeletion Syndrome.

Authors:  Tehila Stern; Emeline H Crutcher; John M McCarthy; May A Ali; Gil Issachar; Amir B Geva; Ziv Peremen; Christian P Schaaf
Journal:  Front Neurosci       Date:  2021-01-28       Impact factor: 4.677

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.